首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

市場調查報告書

商品編碼

1447017

到 2030 年雙室預充式注射器市場預測 - 各產品類型、類型、適應症、材料、配銷通路、應用和地理位置的全球分析

Dual Chamber Prefilled Syringes Market Forecasts to 2030 - Global Analysis By Product Type, Type, Indication, Material, Distribution Channel, Application and by Geography

出版日期: 2024年03月03日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，2023 年全球雙房預充式注射器市場規模為 1.6872 億美元，預計到 2030 年將達到 3.0448 億美元，預測期內複合CAGR為 8.8%。雙室預充式注射器提供了一種簡化的方法，可以輕鬆管理兩種不同的物質，標誌著藥物傳輸技術的重大進步。這些注射器上有兩個隔間，裡面有單獨的組件或藥物。由於該設計，藥物可以單獨儲存並同時混合，從而在注射之前保持藥物的效力和穩定性。此外，這種新方法在需要兩種藥物的組合才能達到給定治療效果的情況下特別有用。

根據國際藥用輔料理事會 (IPEC) 的說法，雙室預充式注射器代表了藥物傳輸技術的重大進步。這些注射器具有兩個獨立的室，通常設計用於儲存和隔離不同的成分，例如藥物和稀釋劑。

市場動態：

驅動因素：

提高藥物穩定性

雙室預充式注射器對於解決某些藥物帶來的穩定性問題至關重要。這些注射器在給藥前將各個藥物成分保持分開，從而避免過早混合，避免過早混合而促使分解。此外，這項功能對於容易出現物理或化學不穩定的藥物尤其重要，因為它可以保證患者以最佳狀態接受藥物，從而改善治療效果。

阻礙因素：

複雜的製造工序

雙室預充式注射器有許多優點，但複雜的製造過程帶來了一些困難。由於這些注射器的複雜構造和組裝，生產成本可能會上升，這需要確保適當的零件隔離並保持整體結構完整性。此外，製造商必須解決這些複雜問題，以最大限度地提高生產效率和成本效益，這可能會影響雙室預充式注射器的普遍使用。

機會：

特定藥物配方的個體化

市場的一大機會是能夠根據各種藥物配方的獨特需求訂製雙室預充式注射器。製造商和製藥公司可以密切合作，生產專門設計用於滿足各種藥物需求的注射器。此外，這種個人化可以提高雙室注射器對各種藥物的適用性和效率，並鼓勵製藥業的合作和聯盟。

威脅：

市場飽和與競爭環境

雙室預灌封注射器市場存在競爭加劇和最終市場飽和的風險。隨著更多製造商進入市場，過度飽和可能會導致價格戰和利潤率下降。此外，為了保持競爭力並有效應對潛在的市場飽和，公司需要透過創新、品質和策略合作夥伴關係來使其產品脫穎而出。

Covid-19 影響：

由於 COVID-19 大流行，雙房預充式注射器市場既經歷了機遇，也面臨課題。一方面，由於全球各地對疫苗接種活動的日益關注，預充式注射器（包括雙室型號）的需求量很大。這些注射器可為疫苗提供準確、高效的藥物輸送。但由於製造業停滯、全球供應鏈中斷以及對醫療保健支出的審查加強，出現了一些困難。此外，大流行加速了新型藥物輸送解決方案的採用，並凸顯了強大供應鏈的重要性。

預計糖尿病領域在預測期內將是最大的領域

在雙室預充式注射器市場中，糖尿病市場預計將佔據最大佔有率。全球糖尿病盛行率增加了對準確實用的給藥系統的需求。具有兩個腔室的預充式注射器對於需要在給藥前混合胰島素成分或重新配製藥物的糖尿病患者特別有用。此外，這些注射器提供了更好的準確性，降低了劑量錯誤的可能性，並提高了患者對胰島素時間表的依從性。

塑膠領域預計在預測期內複合CAGR最高

在雙室預灌封注射器市場中，塑膠領域的CAGR最高。許多因素促成了這種成長。由於其固有的靈活性，塑膠預灌封注射器具有更好的抗破裂性、玻璃破碎機會更低和安全性更高等優點。此外，塑膠注射器更易於操作和攜帶。此外，眾所周知，塑膠注射器比玻璃注射器便宜。該市場塑膠領域的強勁擴張歸因於獸醫、生物技術和製藥等各種應用對雙室預充式注射器的需求不斷成長。

佔比最大的地區：

在市場上，北美佔據最大佔有率。由於各種因素，該領域的市場顯著成長。北美因其成熟的生物技術和製藥行業以及對尖端醫療技術和醫療保健基礎設施的重視而引領該市場。此外，研發活動投資的增加以及對新型給藥系統的強勁需求也有助於雙室預充式注射器在該地區的採用。

複合CAGR最高的地區：

雙室預灌封注射器市場的CAGR在亞太地區最高。許多因素對該地區的顯著擴張發揮了作用。亞太地區經濟的快速發展帶來了更好的醫療基礎設施和更高的醫療支出。因此，對複雜的藥物輸送裝置（例如雙室預充式注射器）的需求增加了。此外，人口老化、慢性病盛行率上升以及人們對預充式注射器優勢的認知不斷加深，都促進了該地區市場的擴張。

主要進展：

2024 年 2 月，全球領先的製藥和生物技術公司拜耳 (BAYRY) 與科學數據和人工智慧雲公司 TetraScience 宣布達成協議，旨在最大限度地發揮科學資料的價值並推動創新。此次合作將支持拜耳的使命，即提供下一代改變生活的療法並確保全球糧食安全。

2023 年11 月，Gerresheimer 在墨西哥克雷塔羅的玻璃工廠舉行了奠基儀式，慶祝其工廠擴建工程開工。這家製藥和化妝品玻璃製造商將投資約1 億歐元在位於墨西哥克雷塔羅的新建築和新生產線建設。其克雷塔羅工廠。這將使其北美市場的注射器製造能力每年增加數億支「即用型」(RTF) 注射器。

2023 年5 月，全球醫療保健技術領導者美敦力公司(Medtronic plc) 今天宣布，已簽訂一系列最終協議，收購EOPatch(R) 設備（一種無管、穿戴式和完全一次性胰島素）的製造商EOFlow Co. Ltd.輸送裝置。 EOFlow 的加入，與美敦力(Medtronic) 的膳食檢測技術(TM) 演算法和下一代連續血糖監測儀一起，預計將擴大該公司滿足更多醣尿病患者需求的能力，無論他們處於治療過程中的哪個階段，還是在治療過程中。他們希望如何輸送胰島素的偏好。

我們的報告提供了什麼：

區域和國家層面的市場佔有率評估
對新進入者的策略建議
涵蓋2021年、2022年、2023年、2026年及2030年的市場資料
市場趨勢（促進因素、限制因素、機會、威脅、課題、投資機會和建議）
根據市場預測提出關鍵業務部門的策略建議
競爭性景觀美化繪製主要共同趨勢
公司概況，包括詳細的策略、財務狀況和最新發展
反映最新技術進步的供應鏈趨勢

免費客製化產品：

本報告的所有客戶都將有權獲得以下免費自訂選項之一：

公司簡介
- 其他市場參與者的綜合分析（最多 3 個）
- 關鍵參與者的 SWOT 分析（最多 3 個）
區域區隔
- 根據客戶的興趣對任何主要國家的市場估計、預測和CAGR（註：取決於可行性檢查）
競爭基準化分析
- 根據產品組合、地理分佈和策略聯盟對主要參與者基準化分析

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 亞太地區其他地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 中東和非洲其他地區

第 12 章：主要進展

協議、夥伴關係、合作和合資企業
收購與合併
新產品發布
擴充
其他關鍵策略

第 13 章：公司概況

Gerresheimer AG
Medtronic
Bayer AG
Nipro Corporation
Elcam Drug Delivery Devices
Pfizer Inc.
Novartis AG
AbbVie Inc.
Mylan N.V.
Otsuka America Pharmaceutical, Inc.
Credence MedSystems Inc.
Vetter Pharma-Fertigung GmbH & Co. KG
Maeda Industry Co. Ltd.
Catalent, Inc.
Terumo Europe NV
West Pharmaceutical Services, Inc.
Schott AG

簡介目錄圖表

Product Code: SMRC25278

According to Stratistics MRC, the Global Dual Chamber Prefilled Syringes Market is accounted for $168.72 million in 2023 and is expected to reach $304.48 million by 2030 growing at a CAGR of 8.8% during the forecast period. Dual Chamber Prefilled syringes, which provide a simplified method for the easy administration of two different substances, mark a substantial advancement in drug delivery technology. There are two compartments on these syringes, and inside are separate components or medications. Drugs can be stored separately and mixed simultaneously thanks to the design, which maintains the drug's potency and stability until injection time. Moreover, this novel approach is especially useful in situations where the combination of two drugs is necessary for a given therapeutic effect.

According to the International Pharmaceutical Excipients Council (IPEC), dual chamber prefilled syringes represent a significant advancement in drug delivery technology. These syringes feature two separate chambers, typically designed to store and isolate different components, such as a drug and a diluent.

Market Dynamics:

Driver:

Improved medicine stability

Dual-chamber prefilled syringes are essential for resolving issues with stability that come with some medications. These syringes avoid premature mixing that can cause degradation by keeping individual drug components apart until the point of administration. Additionally, this feature is especially important for medications that are prone to physical or chemical instability because it guarantees that patients receive their medications in the best possible state, which improves therapeutic outcomes.

Restraint:

Intricate manufacturing procedures

Dual-chamber prefilled syringes have benefits, but complicated manufacturing procedures present some difficulties. Production costs may rise as a result of the complex construction and assembly of these syringes, which entails guaranteeing appropriate component isolation and upholding structural integrity overall. Furthermore, these intricacies must be resolved by manufacturers in order to maximize production efficiency and cost-effectiveness, which may have an effect on the general use of dual-chamber prefilled syringes.

Opportunity:

Individualization for particular drug formulations

One major opportunity to the market is the ability to tailor dual-chamber prefilled syringes to the unique needs of various drug formulations. Manufacturers and pharmaceutical companies can collaborate closely to create syringes that are specifically designed to meet the needs of various medications. Moreover, this personalization can improve dual chamber syringes' suitability and efficiency for a variety of medications, encouraging cooperation and alliances in the pharmaceutical sector.

Threat:

Market saturation and the competitive environment

There is a risk of growing competition and eventual market saturation in the dual-chamber prefilled syringe market. There's a chance that oversaturation will result in price wars and narrower profit margins as more manufacturers enter the market. Additionally, to remain competitive and effectively navigate potential market saturation, companies need to differentiate their products through innovation, quality, and strategic partnerships.

Covid-19 Impact:

The market for dual-chamber prefilled syringes has experienced both opportunities and challenges as a result of the COVID-19 pandemic. On the one hand, prefilled syringes, including dual chamber models, are in high demand due to the increased focus on vaccination campaigns around the globe. These syringes offer accurate and efficient drug delivery for vaccines. But there have been difficulties due to manufacturing hold-ups, disruptions in global supply chains, and increased scrutiny of healthcare spending. Furthermore, the pandemic has accelerated the adoption of novel drug delivery solutions and highlighted the significance of robust supply chains.

The Diabetes segment is expected to be the largest during the forecast period

In the market for dual-chamber prefilled syringes, the diabetes segment is predicted to hold the largest share. Global diabetes prevalence has increased demand for accurate and practical drug delivery systems. Prefilled syringes with two chambers are especially useful for diabetics who need to mix the components of insulin or reconstitute medications before administering them. Moreover, these syringes provide better accuracy, lower the possibility of dosage mistakes, and increase patient compliance with insulin schedules.

The Plastic segment is expected to have the highest CAGR during the forecast period

In the dual chamber prefilled syringe market, the plastic segment has shown the highest CAGR. Numerous factors contribute to this growth. Because of their inherent flexibility, plastic prefilled syringes have advantages like better break resistance, a lower chance of glass breaking, and increased safety. Additionally, plastic syringes are simpler to handle and carry. Furthermore, it's common knowledge that plastic syringes are less expensive than glass syringes. The strong expansion of the plastic segment in this market has been attributed to the growing need for dual chamber prefilled syringes in a variety of applications, including veterinary medicine, biotechnology, and pharmaceuticals.

Region with largest share:

In the market, North America holds the largest share. The market in this area has grown significantly as a result of various factors. North America leads this market because of its well-established biotechnology and pharmaceutical sectors, as well as its emphasis on cutting-edge medical technologies and healthcare infrastructure. Additionally, the adoption of dual-chamber prefilled syringes in the region has also been aided by increased investment in research and development activities and a strong demand for novel drug delivery systems.

Region with highest CAGR:

The dual chamber prefilled syringe market has shown the highest CAGR in the Asia-Pacific region. Numerous elements have played a role in the remarkable expansion of the area. Rapid economic development in the Asia-Pacific area has resulted in better healthcare infrastructure and higher healthcare spending. The need for sophisticated drug delivery devices, such as dual-chamber prefilled syringes, has therefore increased. Moreover, the aging population, increased prevalence of chronic illnesses, and growing knowledge of the advantages of prefilled syringes have all contributed to the region's market expansion.

Key players in the market

Some of the key players in Dual Chamber Prefilled Syringes market include Gerresheimer AG, Medtronic, Bayer AG, Nipro Corporation, Elcam Drug Delivery Devices, Pfizer Inc., Novartis AG, AbbVie Inc., Mylan N.V., Otsuka America Pharmaceutical, Inc., Credence MedSystems Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Maeda Industry Co. Ltd., Catalent, Inc., Terumo Europe NV, West Pharmaceutical Services, Inc. and Schott AG.

Key Developments:

In February 2024, Bayer AG (BAYRY), a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, announced an agreement aimed at maximizing the value of scientific data and driving innovation. This collaboration will support Bayer's mission to deliver the next generation of life-changing therapeutics and ensure global food security.

In November 2023, Gerresheimer held a groundbreaking ceremony at its glass facility in in Queretaro, Mexico to celebrate the start of construction for its plant expansion.The pharmaceutical and cosmetics glass manufacturer will invest approximately €100 million in a new building and new production lines at its Queretaro plant. This will increase its manufacturing capacity for syringes for the North American market by several hundred million "ready-to-fill" (RTF) syringes annually.

In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor, is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

Product Types Covered:

Conventional Prefilled Syringes
Safety Prefilled Syringes
Other Product Types

Types Covered:

<1 ml
1 ml-2.5 ml
2.5 ml-5.0 ml
>5.0 ml
Other Types

Indications Covered:

Hemophilia
Schizophrenia
Diabetes
Erectile Dysfunction
Endometriosis
Other Indications

Materials Covered:

Glass
Plastic
Other Materials

Distribution Channels Covered:

Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

Applications Covered:

Liquid/Powder
Liquid/Liquid
Liquid/Lyophilisate
Other Applications

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Dual Chamber Prefilled Syringes Market, By Product Type

5.1 Introduction
5.2 Conventional Prefilled Syringes
5.3 Safety Prefilled Syringes
5.4 Other Product Types

6 Global Dual Chamber Prefilled Syringes Market, By Type

6.1 Introduction
6.2 <1 ml
6.3 1 ml-2.5 ml
6.4 2.5 ml-5.0 ml
6.5 >5.0 ml
6.6 Other Types

7 Global Dual Chamber Prefilled Syringes Market, By Indication

7.1 Introduction
7.2 Hemophilia
7.3 Schizophrenia
7.4 Diabetes
7.5 Erectile Dysfunction
7.6 Endometriosis
7.7 Other Indications

8 Global Dual Chamber Prefilled Syringes Market, By Material

8.1 Introduction
8.2 Glass
8.3 Plastic
8.4 Other Materials

9 Global Dual Chamber Prefilled Syringes Market, By Distribution Channel

9.1 Introduction
9.2 Hospitals Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies

10 Global Dual Chamber Prefilled Syringes Market, By Application

10.1 Introduction
10.2 Liquid/Powder
10.3 Liquid/Liquid
10.4 Liquid/Lyophilisate
10.5 Other Applications

11 Global Dual Chamber Prefilled Syringes Market, By Geography

11.1 Introduction
11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa

12 Key Developments

12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling

13.1 Gerresheimer AG
13.2 Medtronic
13.3 Bayer AG
13.4 Nipro Corporation
13.5 Elcam Drug Delivery Devices
13.6 Pfizer Inc.
13.7 Novartis AG
13.8 AbbVie Inc.
13.9 Mylan N.V.
13.10 Otsuka America Pharmaceutical, Inc.
13.11 Credence MedSystems Inc.
13.12 Vetter Pharma-Fertigung GmbH & Co. KG
13.13 Maeda Industry Co. Ltd.
13.14 Catalent, Inc.
13.15 Terumo Europe NV
13.16 West Pharmaceutical Services, Inc.
13.17 Schott AG

簡介目錄圖表

List of Tables

Table 1 Global Dual Chamber Prefilled Syringes Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Dual Chamber Prefilled Syringes Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Dual Chamber Prefilled Syringes Market Outlook, By Conventional Prefilled Syringes (2021-2030) ($MN)
Table 4 Global Dual Chamber Prefilled Syringes Market Outlook, By Safety Prefilled Syringes (2021-2030) ($MN)
Table 5 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 6 Global Dual Chamber Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
Table 7 Global Dual Chamber Prefilled Syringes Market Outlook, By <1 ml (2021-2030) ($MN)
Table 8 Global Dual Chamber Prefilled Syringes Market Outlook, By 1 ml-2.5 ml (2021-2030) ($MN)
Table 9 Global Dual Chamber Prefilled Syringes Market Outlook, By 2.5 ml-5.0 ml (2021-2030) ($MN)
Table 10 Global Dual Chamber Prefilled Syringes Market Outlook, By >5.0 ml (2021-2030) ($MN)
Table 11 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Types (2021-2030) ($MN)
Table 12 Global Dual Chamber Prefilled Syringes Market Outlook, By Indication (2021-2030) ($MN)
Table 13 Global Dual Chamber Prefilled Syringes Market Outlook, By Hemophilia (2021-2030) ($MN)
Table 14 Global Dual Chamber Prefilled Syringes Market Outlook, By Schizophrenia (2021-2030) ($MN)
Table 15 Global Dual Chamber Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
Table 16 Global Dual Chamber Prefilled Syringes Market Outlook, By Erectile Dysfunction (2021-2030) ($MN)
Table 17 Global Dual Chamber Prefilled Syringes Market Outlook, By Endometriosis (2021-2030) ($MN)
Table 18 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Indications (2021-2030) ($MN)
Table 19 Global Dual Chamber Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
Table 20 Global Dual Chamber Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
Table 21 Global Dual Chamber Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
Table 22 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Materials (2021-2030) ($MN)
Table 23 Global Dual Chamber Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 24 Global Dual Chamber Prefilled Syringes Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
Table 25 Global Dual Chamber Prefilled Syringes Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 26 Global Dual Chamber Prefilled Syringes Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 27 Global Dual Chamber Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
Table 28 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Powder (2021-2030) ($MN)
Table 29 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Liquid (2021-2030) ($MN)
Table 30 Global Dual Chamber Prefilled Syringes Market Outlook, By Liquid/Lyophilisate (2021-2030) ($MN)
Table 31 Global Dual Chamber Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)